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Background: To determine the effects of inferior alveolar nerve transection (IAN-X) on masticatory movements in
freely moving rats and to test if microglial cells in the trigeminal principal sensory nucleus (prV) or motor nucleus
(motV) may be involved in modulation of mastication, the effects of microglial cell inhibitor minocycline (MC) on
masticatory jaw movements, microglia (Iba1) immunohistochemistry and the masticatory jaw movements and
related masticatory muscle EMG activities were studied in IAN-X rats.
Results: The number of Iba1-immunoreactive (IR) cells both in prV and motV was significantly larger in IAN-X rats
compared with sham rats on day 3 after IAN-X. The intraperitoneal (i.p.) administration of MC caused a significant
reduction of the number of Iba1-IR cells both in prV and motV that was evident on day 14 after IAN-X.
Furthermore, a significant reduction of the number of Iba1-IR cells could be observed in motV but not in prV after
microinjection (m.i.) of MC into the motV of IAN-X rats. The rats also exhibited a significant decrease in the head-
withdrawal threshold on the side ipsilateral to the IAN-X compared to the threshold before IAN-X and it lasted to
day 14. In addition, IAN-X markedly affected the ability to rat to carry out mastication. The number of complete
masticatory sequences was significantly decreased. Furthermore, the total masticatory sequence time and food
preparatory (PP) period duration was significantly elongated in compared to sham rats. Although IAN-X significantly
affected the total number of chewing cycles within the RC period of a masticatory sequence, it had no effect on
the duration of the chewing cycles. On the other hand, systemic administration of MC (both i.p. and m.i.) in IAN-X
rats significantly improved decreased head-withdrawal threshold and the impaired masticatory jaw movements.
Conclusions: The present findings reveal that the strong modulation of masticatory jaw movements occurs
following microglial cell activation after IAN-X, and the modulation recovers after inhibition of the microglial cell
activation by MC, suggesting that microglial cell activation in the motV as well as in the prV has a pivotal role in
modulating mastication following trigeminal nerve injury associated with orofacial neuropathic pain.
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It is well known that jaw movements during mastica-
tion activate various intraoral sensory receptors that
are involved in providing sensory feedback to the
brain to guide masticatory jaw movements [1-4], sen-
sory inputs related specifically to pain can modulated
masticatory movements and other jaw motor func-
tions [5-11]. Thus, noxious inputs from intraoral tis-
sues can modulate masticatory movements. However,
little is known about the mechanisms by which
chronic orofacial pain may affect masticatory move-
ments. Orofacial persistent pain is frequently observed
following trauma of the trigeminal nerve. It is however
now clear that trigeminal nerve injury can produce a
neuropathic pain condition that is associated with
central sensitization of trigeminal brainstem nocicep-
tive neurons on subnucleus caudalis (Vc) [12-15], and
that the normal hyperexcitability depends on the func-
tional insights of glia [14,16-19].
Indeed, in addition to the importance of neuronal
mechanisms underlying orofacial neuropathic pain and
modulation of motor functions, there is considerable
evidence that glial cells in pain signaling pathways
may play an important role both in sensory and
motor functions. While hyperactive glial cells have
been reported mainly in the Vc and upper cervical
dorsal horn (C1-C2) after peripheral nerve injury or
inflammation and have been recognized for their role
in initiating or maintaining neuropathic pain, it has
also been reported that glial cells are activated sur-
rounding the prV [19] and facial motor nuclei [20]
following peripheral nerve injury.
Furthermore, other recent evidence suggests that glial
cells may play an important role in controlling the activ-
ity of the neuronal networks underlying motor functions
[21-23]. However, no studies have been conducted in
animal neuropathic pain models to evaluate whether
trigeminal nerve injury affects masticatory movements
and whether glial cells are involved in the modulation of
orofacial motor functions after the nerve injury. We
hypothesized that microglial cells in or adjacent to the
motV as well as the prV are activated after IAN injury
and such hyperactive microglial cells might be involved
in the nerve injury-induced modulation of masticatory
movements.
MC, tetracycline derivative, is known to attenuate
the abnormal pain behavior by the inhibition of the
microglial activity [24-33], and thereby improve the
motor behaviors [28]. Our hypothesis was that admin-
istration of MC may also be effective for the im-
provement of masticatory movements after IAN-X.
Thus, the aim of the present study was (1) to deter-
mine the effects of IAN-X on masticatory movements in
freely moving rats, (2) to test if microglia in the prV ormotV may be involved in modulation of these effects
and (3) the effect of MC on the masticatory movements
following the IAN-X in freely moving rats.
Results
Microglial cell activation in prV and motV
The Iba1 immunohistochemical study was conducted to
visualize activated microglial cells, and the distribution
pattern of Iba1-immunoreactive (IR) cells was studied in
IAN-X rats (Figure 1). Some previous studied have
reported that Iba1-IR cells are found in the Vc [17-19],
but the present study focused on prV and motV. A large
number of Iba1-IR cells were observed both in the prV
and motV in IAN-X rats (Figure 1A, C, D). The number
of Iba1-IR cells was significantly larger in IAN-X rats
compared with sham rats on day 3 after IAN-X both in
the prV and motV (Figure 1Ab, Ai, Ac, Aj, 1C-D) and
was slightly reduced on day 14 (Figure 1Ad, Ak, 1C-D).
Since MC is known to attenuate the activation of micro-
glial cells in the spinal dorsal horn after spinal cord injury
[27,28,31,34]), we studied the effect of i.p. or m.i. of MC
into the motV on Iba1-IR cell expression in IAN-X rats
(Figure 1A, C, D). The i.p. administration of MC caused a
significant reduction of the number of Iba1-IR cells both
in the prV and motV on day 14 after IAN-X (Figure 1Ag,
An, 1C-D). Furthermore, a significant reduction of the
number of the Iba1-IR cells was observed in the motV
after m.i. of MC into the motV (Figure 1Ao, 1D). On the
other hand, we could not observe any significant changes
in the number of Iba1-IR cells in the prV after m.i. of MC
into the motV (Figure 1Ah, 1C), indicating that the
injected MC was not extending into the prV. In addition,
no significant changes in the number of the Ib1-IR cells
was observed both in the prV and motV after saline ad-
ministration (i.p. or m.i. into the motV) in IAN-X rats
(Figure 1Ae, Al, Af, Am, 1C-D).
Distribution of FG-labeled neurons in TG
FG tracing study of the trigeminal ganglion neurons was
conducted for evidence suggesting the regeneration and
reinnervation by the transected IAN [15,35]. FG-labeled
neurons were localized in the root of the third branch of
the trigeminal nerve (Additional File 1: Figure S1B,
S1C). In sham rats, a large numbers of FG-labeled neu-
rons were observed in the TG (Additional File 1: Figure
S1Bb, S1C). No or few labeled neurons were observed at
day 3 after IAN-X (Additional File 1: Figure S1Bc, S1C).
However, the number of FG-labeled neurons was
increased at day 7 after IAN-X in compared with that at
day 3 after IAN-X (Additional File 1: Figure S1Bd, S1C).
The large number of FG-labeled neurons was apparent
in the TG at day 14 after IAN-X (Additional File 1: Fig-
ure S1Be, S1C). It is notable that we could not observe
any FG-labeled neurons in the root of the second branch
Figure 1 A: Temporal profile of the microglial cell activation in the prV and motV. In the case of IAN-X rats, microglial cells were immuno-
labeled with Iba1 in the prV and motV at 3 (n= 5) and 14 day (n= 5) after IAN-X. In the sham (n=5) or IAN-X+MC-injected (both the i.p., n = 5 and m.
i., n = 5) or IAN-X+ saline-injected rats (i.p., n = 5 and m.i., n = 5), microglial cells were immuno-labeled after 14 days. B: Localization of the m.i. site in the
motV. The number of Iba1-immunoreactive (IR) cells in the three sections per rats (C-D). The Iba1-IR cells were increased at 3 day after IAN-X both in
the prV (C) and motV (D). After 14 days, a small decrease in these cells was observed in IAN-X rats. The i.p. administration of MC strongly attenuated
the number of Iba1-IR cells both in the prV and motV. It is notable that m.i. into motV strongly attenuated the number of Iba1-IR cell in the motV but
not in the prV. (*) denotes the significant difference between experimental groups (p< 0.05, one way ANOVA with tukey test).
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itional File 1: Figure S1Ba).
Head-withdrawal threshold to mechanical stimulation of
mental skin
During behavioral testing, rats stayed in the plastic cage
quietly and protruded their nose through the hole in thefront wall of the cage without any discomfort. Rats also did
not show vocalization or autotomy during measurement of
the head-withdrawal threshold to mechanical stimulation
of the mental skin. Before the IAN-X operation (pre in Fig-
ure 2A, B), the mean mechanical head-withdrawal thresh-
old was 20.0 +/− 4.0 g (mean +/− SD, n=12) on the side
ipsilateral to the IAN-X and 22.0 +/− 3.6 g on the side
Figure 2 Change in the head-withdrawal threshold to mechanical stimulation of the mental skin and whisker pad skin. A: Mechanical head-
withdrawal threshold in the mental skin ipsilateral to the sham operation (n=12) and IAN-X (n=12), B: Mechanical head-withdrawal threshold in the
mental skin contralateral to the sham operation and IAN-X, C: Mechanical head-withdrawal threshold in the mental skin ipsilateral to IAN-X after MC (i.p.,
n=12 and m.i., n= 10) and saline (i.p., n=10 and m.i., n=10) administration, D: Mechanical head-withdrawal threshold in the mental skin contralateral to
IAN-X after MC (i.p., and m.i.,) and saline (i.p., and m.i.,) administration, E: Mechanical head-withdrawal threshold in the whisker pad skin ipsilateral to the
sham operation (n=12) and IAN-X (n=12), F: Mechanical head-withdrawal threshold in the whisker pad skin contralateral to the sham operation and IAN-
X, G: Mechanical head-withdrawal threshold in the whisker pad skin ipsilateral to IAN-X after MC (i.p., n=12 and m.i., n=10) and saline (i.p., n=10 and m.i.,
n= 10) administration, H: Mechanical head-withdrawal threshold in the whisker pad skin contralateral to IAN-X after MC (i.p., and m.i.,) and saline (i.p., and
m.i.,) administration. The arrow in the graph indicates the time point of the sham operation or IAN-X. The behavioral test was assessed once a day for
14 days, and the median value was adopted. It is notable that the mechanical head-withdrawal threshold was significantly decreased 14 days after IAN-X,
and administration of MC (both i.p. and m.i.) significantly attenuated the reduction on the head-withdrawal threshold 14 days after IAN-X. Pre: the day
before sham or IAN-X, a indicates: pre-IAN-X vs. post-IAN-X, b indicates: sham vs. IAN-X, c indicates: pre-IAN-X+MC (i.p.) vs. post-IAN-X+MC (i.p.), pre-IAN-
X+MC (m.i.) vs. post-IAN-X+MC (m.i.), pre-IAN-X+ saline (i.p.) vs. post-IAN-X+ saline (i.p.), pre-IAN-X+ saline (m.i.) vs. post-IAN-X+ saline (m.i.), d indicates:
IAN-X+MC (i.p.) vs. IAN-X+MC (m.i.), IAN-X+MC (i.p.) vs. IAN-X+ saline (i.p.) and IAN-X+MC (i.p.) vs. IAN-X+ saline (m.i.), e indicates: IAN-X+MC (m.i.) vs.
IAN-X+ saline (i.p.) and IAN-X+MC (m.i.) vs. IAN-X+ saline (m.i.), p< 0.05 was considered significant (one way ANOVA with Tukey test, and Dunnett’s test
for pre vs. post IAN-X or pre vs. post IAN-X+MC or pre vs. post IAN-X+ saline).
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ical head-withdrawal threshold on the side ipsilateral to the
IAN-X was significantly increased (62.4 +/− 4.6 g, n=12)
on day 3 after the IAN-X compared to that before the IAN-
X operation and compared to that in sham rats (before op-
eration: 20 +/− 4.0 g, sham: 20.2 +/− 3.0, n =12 in each)
(Figure 2A), whereas no significant change in the head-
withdrawal threshold was observed on the side contralat-
eral to the IAN-X (22.2 +/− 3.4 g, n=12) at day 3 after
IAN-X (Figure 2B). Four days after the IAN-X, the head-
withdrawal threshold began to decrease, and a significant
decrement in the head-withdrawal threshold could be
observed in the side ipsilateral to the IAN-X on day 7 com-
pared with that before operation (before IAN-X: 20 +/−
4.0 g, IAN-X on day 7 :10.2 +/− 2.0 g, n=10), and lasted
until day 14 (Figure 2A). On the other hand, there was no
significant change in the head-withdrawal threshold on the
side contralateral to the IAN-X and in sham rats (Figure 2A,
B).
To examine the effect of MC on nocifensive behavior
following the IAN-X, we measured the head-withdrawal
threshold to mechanical stimulation of the mental skin in
IAN-X rats after i.p. injection of MC (n=12) and after m.
i. injection of MC into the motV (n= 10) (Figure 2C, D).
The head-withdrawal threshold to mechanical stimulation
of the mental skin in IAN-X+ saline-injected rats (i.p., or
m.i. into the motV) on day 14 after IAN-X was signifi-
cantly lower than that before the IAN-X operation (saline
(i.p.): 3.3 +/− 2.0 g, saline (m.i.): 3.9 +/− 1.7 g, before IAN-
X: 20.1 +/− 3.5 g, n = 10) (Figure 2C). On the other hand,
on day 14 after the daily administration of MC (i.p., or m.
i. into the motV), the reduction of the head-withdrawal
threshold to mechanical stimulation of the mental skin in
IAN-X rats was significantly attenuated (MC (i.p.) : 17.0
+/− 2.6 g, MC (m.i.): 15.2 +/− 1.0 g) (Figure 2C). There
was no significant influence of MC or saline on the head-
withdrawal threshold on the side contralateral to the IAN-
X or sham operation (Figure 2D).
Head-withdrawal threshold to mechanical stimulation of
whisker pad skin
Our previous study documented that mechanical hypersen-
sitivity was developed in the whisker pad skin innervated by
the infra-orbital nerve at the early period after IAN-X [13].
Thus, the mechanical head-withdrawal threshold was also
investigated in the whisker pad skin. Before the IAN-X, the
mean mechanical head-withdrawal threshold was 51.0 +/−
8.0 g (mean +/− SD, n=12) on the side ipsilateral to the
IAN-X and 59.0 +/− 6.0 g on the side contralateral to the
IAN-X (Figure 2E, 2F). After the IAN-X, the head-with-
drawal threshold to mechanical stimulation of whisker pad
was significantly decreased on day 3 in the side ipsilateral to
the IAN-X compared with sham rats (IAN-X: 5.1 +/− 2.4 g,
sham: 54.0 +/− 6.1 g) (Figure 2E). The significant decrementof the head-withdrawal threshold was observed at least
14 days after IAN-X (IAN-X: 6.1 +/− 1.0 g) (Figure 2E). In
addition, a weak reduction of head-withdrawal threshold
was observed on the side contralateral to the IAN-X
(Figure 2F).
After administration of MC (i.p. or m.i. into the motV)
once daily for 14 days, the reduction of head-withdrawal
threshold to mechanical stimulation in the whisker pad
was significantly attenuated in the IAN-X rats (Figure 2G).
On the other hand, administration of saline (i.p. or m.i.
into the motV) in the IAN-X rats did not affect the head-
withdrawal threshold (Figure 2G). In addition, there was
no significant influence of MC or saline on the head-with-
drawal threshold on the side contralateral to the IAN-X or
sham operation (Figure 2H).Modulation of masticatory jaw movements
During masticatory jaw movements recording in sham
rats, rats were stayed in the plastic cage without any sign
of discomfort. Each animal could readily ingest the food
when the food was presented in front of the rat’s mouth.
As described in the Methods section, the entire mastica-
tory sequence was divided into the PP and RC periods on
the basis of EMG activities and jaw-movement patterns
(Figure 3A). The PP period was characterized by the sev-
eral cycles of simple open-close movements with irregular
cycle duration following the initial jaw opening. During
the RC period, the animal began to crush and grind the
food between the upper and lower molars when the food
was transferred to the posterior part of the mouth. This
period needed a longer duration to grind the food com-
pared to food preparation. Unlike from the PP period, the
RC period is characterized by the prominent horizontal
excursion of the jaw (Figure 3A).
The masseter muscles were activated in the jaw-closing
phase throughout the RC period and the digastric muscles
showed prominent rhythmic EMG bursts in relation to
the jaw-opening phase (Figure 3A). Rhythmic bilateral
shifts of the jaw (Type-I: both right and left side, 3400
(85%) chewing cycle out of 3981) were observed during
the RC period in the sham rats (Figure 4B-C). A unilateral
shift of the jaw (Type-II: 10%, Type-III: 5%) during this
period was rarely observed. During chewing cycles, the
animals also performed a series of stable jaw-opening and
-closing movements during the RC period, and 42.0 +/−
5.0 chewing cycles were found in each RC period of the
masticatory sequence (Figure 5E).
Jaw-muscle activities and jaw-movement patterns in
three dimensions of the masticatory sequence were also
studied in IAN-X rats (Figure 3B). It was frequently
observed that IAN-X rats failed to ingest the food and
dropped it. In addition, masticatory jaw movements with
irregular large horizontal shifts with prominent jaw-
Figure 3 Typical examples of masticatory sequences. A entire masticatory sequence in sham rats (A), IAN-X rats (B), IAN-X + saline rats (i.p.)
(C, upper graph), IAN-X + saline (m.i.) (C, lower graph), IAN-X+MC (i.p.) rats (D, left sided graph) and IAN-X +MC (m.i.) rats (D, right sided graph).
The recordings include horizontal, anterior/posterior and vertical components of the jaw-movement trajectories and EMG activities of the
digastric and masseter muscles. Whole masticatory sequences were defined as the period of intake of food to just before swallowing and was
further divided into two masticatory periods (i.e., the preparatory period and the rhythmic-chewing period) based on the jaw-movement
trajectories and the EMG activities of jaw muscles. It is notable that the masticatory movement was modulated after IAN-X, and administration of
MC in IAN-X rats significantly improved the masticatory behavior.
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the PP period (Figure 3B and see Table 1). Furthermore,
cyclic jaw movements with irregular horizontal excur-
sions of the jaw could be observed during the RC period,
indicating that the rats showed considerable difficulty in
moving their jaw to the IAN-X side during the RC
period (Figures 3B, 4D). The IAN-X rats moved theirjaw to either the contralateral side to the IAN-X site
(Type-II) or made no horizontal excursion of the jaw
(Type-III) during this period (Figure 4B, D). A total of
1689 (74%) chewing cycle out of 2275 (n = 7) was
belongs to the Type-II jaw-movement pattern which was
different from those in the sham rats (Figure 4C-D). It
was also notable that bilateral excursions of the jaw were
Figure 4 Masticatory jaw-movement trajectories in lateral plane during the RC period. A: Jaw-movement trajectories were constructed
based on the vertical and horizontal movements. B: The jaw-movement trajectories were divided into 4 patterns based on the direction of the
horizontal excursion of the jaw, i.e., Type-I (bilateral shift of the jaw), Type-II (jaw moved either contralateral to IAN-X or parallel to the upper jaw),
Type-III (no lateral shift of the jaw), Type-IV (jaw moved only contralateral to IAN-X) and Type-V. The jaw movement patterns in the sham rats (C),
IAN-X (D), IAN-X + saline (i.p.) rats (E), IAN-X+ saline (m.i.) rats (F), IAN-X +MC (i.p.) rats (G) and IAN-X+MC (m.i.) rats (H). In IAN-X rats, bilateral
excursion of the jaw (Type-I) was not apparent. The jaw-movement patterns were expressed as the percentage of the total chewing cycle.
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IAN-X rats seemed to be able to complete the mastica-
tory trails as long as they successfully received and
transported the foods to the occlusal surface of the
molar teeth. The total number of complete masticatory
sequences was significantly shorter in IAN-X rats (11.0
+/− 3.0) compared to sham rats (17.0 +/− 1.0) during
5 min continuous recording (Figure 5A).
The mean masticatory sequence time (19.3 +/− 7.0 s)
was significantly elongated in IAN-X rats compared to
sham rats (12.0 +/− 1.3 s) (Figure 5B). In each mastica-
tory period, duration of PP period was also significantly
longer (12.8 +/− 7.0 s) in the IAN-X rats compared
with sham rats (2.75 +/− 1.0 s) (Figure 5C). Further-
more, the duration of RC period (6.4 +/− 0.5 s) was sig-
nificantly shorter in IAN-X rats than that in sham rats
(9.2 +/− 1.3 s) (Figure 5D). The total number of the
chewing cycles within the RC period (11.0 +/− 2.0) of a
masticatory sequence was also significantly decreased
compared to that in the sham rats (17.5 +/− 1.0)(Figure 5E). However, the pattern of the chewing cycle
as well as the duration of chewing cycle was not
affected by IAN-X during both the PP and RC periods.
Also, no significant change in the duration of the jaw-
closing and -opening phases was observed during both
of these periods (data not shown). In the case of EMG
activities, although mean area of the left masseter EMG
was significantly smaller in the side ipsilateral to the
IAN-X than sham rats, the duration of EMG burst was
not significantly different among experimental groups
(see Table 1).
It is notable that similar modulatory effect on the mas-
ticatory movement was observed at day 3 and 7 after
IAN-X (Additional File 2: Figure S1).
To investigate whether microglial cells are involved in
the modulation of these oro-facial motor functions, we
investigated features of the masticatory jaw movements
after MC (both i.p. and m.i. into motV) or saline admin-
istration (i.p. and m.i. into motV) in the IAN-X rats
(Figure 3C-D). The MC administration (i.p. or m.i.)
Figure 5 Effects of IAN-X, IAN-X+MC (i.p. and m.i.) and IAN-X+ saline (i.p. and m.i.) administration on the number of the masticatory
sequences during 5 min continuous recording (A), mean masticatory sequence time (B), food PP period duration (C) and RC period
duration (D), number of the chewing cycle within the RC period (E). The IAN-X had large effects on the properties of the masticatory
behaviors: decrease in the total number of masticatory sequences during 5 min continuous recording, elongation of the total masticatory
sequence time as well as the food PP period and shortening the RC period. It is notable that administration of MC improved the masticatory
movements in IAN-X rats. (*) denotes the significant difference among the condition of the rats (p< 0.05, one ways ANOVA with tukey test).
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administration of saline (i.p. or m.i.) was ineffective to
significantly influence the masticatory movements in
IAN-X rats (Figure 3C). Masticatory efficacy increased
in IAN-X rats after MC administration, and IAN-X ratscould take and ingest the food without any difficulty
during the recording session (Figure 3D). In addition, a
significant improvement of the jaw-movement patterns
was observed after MC administration (IAN-X+MC
rats) and approximated the patterns seen in the sham
Table 1 A) Duration of the jaw muscle EMG activities, B) Area of the jaw muscle EMG activities
A)
Masticatory periods
PP RC
Duration of jaw muscles (s) Duration of jaw muscles (s)
Jaw-closing muscles Jaw-opening muscles Jaw-closing muscles Jaw-opening muscles
Group R-mass L-mass R-dig L-dig R-mass L-mass R-dig L-dig
sham (n = 7) 0.06+/-0.01 0.06+/-0.01 0.11+/-0.02 0.11+/-0.02 0.08+/-0.01 0.08+/-0.01 0.10+/-0.02 0.10+/-0.01
IAN-X (n = 7) 0.08+/-0.01 0.08+/-0.01 0.10+/-0.01 0.10+/-0.01 0.09+/-0.01 0.08+/-0.01 0.09+/-0.01 0.09+/-0.01
IAN-X + saline (i.p., n = 5) 0.08+/-0.01 0.07+/-0.01 0.10+/-0.01 0.10+/-0.01 0.09+/-0.01 0.07+/-0.01 0.09+/-0.01 0.09+/-0.01
IAN-X + saline (m.i, n = 5) 0.08+/-0.02 0.07+/-0.01 0.11+/-0.02 0.10+/-0.02 0.09+/-0.01 0.08+/-0.01 0.09+/-0.01 0.08+/-0.02
IAN-X + MC (i.p., n = 7) 0.06+/-0.02 0.07+/-0.01 0.10+/-0.02 0.10+/-0.02 0.07+/-0.01 0.08+/-0.01 0.09+/-0.02 0.09+/-0.01
IAN-X + MC (m.i., n = 5) 0.08+/-0.02 0.07+/-0.02 0.10+/-0.02 0.10+/-0.02 0.10+/-0.01 0.08+/-0.01 0.09+/-0.01 0.09+/-0.01
B)
Masticatory periods
PP RC
Area of jaw muscles (s) Area of jaw muscles (s)
Jaw-closing muscles Jaw-opening muscles Jaw-closing muscles Jaw-opening muscles
Group R-mass L-mass R-dig L-dig R-mass L-mass R-dig L-dig
sham (n = 7) 0.006+/-0.001 0.004+/-0.002 0.008+/-0.003 0.010+/-0.004 0.007+/-0.004 0.006+/-0.002 0.006+/-0.003 0.007+/-0.003
IAN-X (n = 7) 0.008+/-0.006 0.002+/-0.001 0.010+/-0.005 0.013+/-0.005 0.010+/-0.004 0.002+/-0.001a 0.010+/-0.005 0.010+/-0.004
IAN-X + saline (i.p., n = 5) 0.008+/-0.006 0.002+/-0.001 0.010+/-0.004 0.010+/-0.005 0.010+/-0.001 0.002+/-0.001b 0.010+/-0.005 0.010+/-0.003
IAN-X + saline (m.i, n = 5) 0.009+/-0.003 0.002+/-0.002 0.009+/-0.003 0.011+/-0.005 0.010+/-0.002 0.002+/-0.002b 0.011+/-0.003 0.010+/-0.002
IAN-X + MC (i.p., n = 7) 0.010+/-0.006 0.003+/-0.002 0.011+/-0.005 0.012+/-0.005 0.012+/-0.006 0.004+/-0.003 0.012+/-0.004 0.011+/-0.003
IAN-X + MC (m.i., n = 5) 0.006+/-0.003 0.003+/-0.003 0.011+/-0.005 0.012+/-0.004 0.007+/-0.002 0.004+/-0.004 0.010+/-0.003 0.008+/-0.003
a indicates that the area of the L-mass in the sham rats was significantly larger than those in the IAN-X rats.
b indicates that the area of the L-mass in the sham rats was significantly larger than those in the IAN-X + saline rats (both i.p. and m.i).
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cursion of the jaw (Type-I) during the RC period,
whereas no significant change in jaw-movement patterns
was observed after administration of saline in IAN-X
rats (Figure 4E-F).
Figure 5A shows the total number of masticatory
sequences during 5 min continuous chewing dramat-
ically increased in MC-injected rats compared to
IAN-X rats or IAN-X + saline rats during 5 min con-
tinuous recording. In addition, the total masticatory
sequence time as well as the duration of the PP and
RC periods in IAN-X +MC rats was not significantly
different from that in sham rats, but different from
those in IAN-X or IAN-X + saline rats (Figure 5B-D).
Furthermore, the number of chewing cycle during
the RC period of each masticatory sequence was also
significantly increased after daily i.p. or m.i. injection
of MC in IAN-X rats compared to IAN-X or IAN-
X + saline rats (Figure 5E).Discussion
This study is the first documentation that trigeminal
nerve injury induces nociceptive behaviors associatedwith alternations of several masticatory patterns, and
that microglial cell activation in the prV and motV is
involved in modulation of masticatory jaw movements
after trigeminal nerve injury, and the present findings
are summarized as follows: 1) IAN-X was associated
with nociceptive behavior and alternations in mastica-
tory motor functions; 2) Significant increase in the num-
ber of activated microglial cells could be observed in the
prV as well as in the motV after IAN-X; 3) Changes in
masticatory EMG activities and jaw movements in IAN-
X rats were attenuated when the microglial cells inhibi-
tor MC was microinjected into the motV or even sys-
temically, and MC also significantly reduced the number
of activated microglial cells in IAN-X rats.Technical considerations
Using awake freely moving rats allowed us to analyze
the modulatory effect of IAN-X during natural mastica-
tion. We were therefore able to study in IAN-X rats, the
modulation of masticatory jaw movements during both
the PP and RC periods. It is very important to analyze
natural masticatory jaw movements in freely moving rats
in order to clarify mechanisms underlying masticatory
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anesthetics) that could affect CNS neuronal activity.
In addition, the IAN was chosen as the target nerve to
prepare the IAN-X model in this study since it is mostly
a pure sensory nerve. Therefore, IAN-X model gave us
the opportunity to study the effects and underlying
mechanisms of a pure sensory nerve lesion without the
motor nerve damage on the masticatory function
[13,35]. Furthermore, we have previously shown that
IAN-X proceeds nociceptive behavior (e.g., lowering the
head withdrawal threshold) and trigeminal central
sensitization [12-15], and that glial cells are involved in
this model of trigeminal neuropathic pain [14,16-19].
Such studies supported the use of this model to study
glial cells involvement in masticatory content changes
following trigeminal nerve injury.Identification of regenerated IAN
It has been reported by the various researchers that the
injured primary afferent nerve fibers regenerate at 2–
3 weeks [36-38]. In the present study, we have observed a
large number of FG-labeled neurons in TG at day 14 after
IAN-X but not at day 3 after IAN-X, indicating that the FG
labeled TG neurons are the result of FG transportation
from the mental skin to the TG. This also indicates that
transected IAN was undergoing regeneration at day 14 after
IAN-X but not at day 3 after IAN-X [15,35].Glial involvement in nocifensive behavior
Our hypothesis was that microglia is involved in devel-
oping of neuropathic pain in the whisker pad skin
innervated by the 2nd branch of the trigeminal nerve
on day 3 after IAN-X, and the neuropathic pain devel-
oped in the whisker pad skin is persist at least 14 days
after IAN-X, and microglial activation is also involved
in developing neuropathic pain in the mental skin on
day 14 after IAN-X. Thus, we investigated the head-
withdrawal threshold to mechanical stimulation of the
whisker pad skin to make sure that the microglial ac-
tivity is directly related to the development of the
neuropathic pain. We have found that mechanical es-
cape threshold was significantly lower than the control
on day 3 after IAN-X and lasted more than 14 days
after IAN-X. Administration of MC decreased the
mechanical hypersensitivity in the whisker pad skin in
IAN-X rats. In addition, our immunohistochemical
analysis showed that microglial cells were activated on
day 3 and lasted at least 14 days after IAN-X. Together
with the immunohistochemical data, the present find-
ings indicate that microglia is involved in the develop-
ment and maintenance of neuropathic pain in the
whisker pad skin and mental skin following IAN-X.Modulation of masticatory jaw movements
We observed a significant reduction of the head-with-
drawal threshold at 14 day after IAN-X, and mastica-
tory jaw movements were strongly modulated at this
time period in the freely moving rats (Figure 3B). IAN-
X rats showed a longer duration to complete mastica-
tion of the food than sham rats, and a considerable dif-
ficulty in preparation and transportation of the food
(Figures 3B, 5B-C). Although IAN-X rats could not
move the jaw ipsilateral to the IAN-X side (Figure 4D),
there were no significant changes in the properties of
the chewing cycles.
Many researchers have reported that the fundamental
pattern of mastication is generated mainly by the cen-
tral pattern generator (CPG) [2,3,39-42], and the essen-
tial core of the CPG lies between the rostral poles of
motV and facial motor nuclei [3,40], the region that
contains the prV [41,42]. The neurons within the prV
receive sensory inputs from muscle spindles, periodon-
tal and other intra-oral mechanoreceptors during masti-
catory jaw movements, and provide the feedback that is
necessary for the modulation of the motor pattern
[41,42]. It has been reported that non-noxious inputs
from intraoral receptors have no or less modulatory ef-
fect on the masticatory jaw movements [43-45], but
noxious inputs from intraoral receptors could modulate
the masticatory jaw movements [5-11]. The clinical pain
or experimental pain from the jaw muscle is associated
with the reduction of the agonist muscle activity during
mastication [5-7,9,10,46], and an increase in antagonist
muscle activity [5,47,48]. For example, noxious inputs
after bilateral injection of hypertonic saline into the
masseter muscles reduced masseter muscle activities in
the agonist phase during mastication [6]. However,
there are also several data that are not consistent with
above observation. For example, it was shown by some
studies that pain did not result in significant reduction
in amplitude of the jaw movement during mastication
or jaw-closing force or masseter EMG [8,47,49]. In
addition, simultaneous increases in the EMG activities
of jaw-closing and -opening muscles were observed fol-
lowing the injections mustard oil or glutamate in the
temporomandibular joint [11,50,51] or jaw muscles
[52]. Furthermore, we observed in the present study
that neuropathic pain induced by the regeneration and
reinnervation of the IAN-X at 14 day affected the abil-
ity to carry out mastication although it did not prevent
mastication from occurring (Figure 3B). Such mastica-
tory impairment is characterized by a significant elong-
ation of the total masticatory time, including PP period
(Figure 5B, C), but there were no or less changes in the
EMG activities both in jaw-closing and -opening mus-
cles (see Table 1). The Possible reasons for the differ-
ences between these studies and our study are the
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the multidimensional nature of pain in the orofacial
regions [9].Microglial involvement in modulation of masticatory jaw
movements
In addition to the importance of the neuronal mechanisms
in the initiation and maintenance of the oro-facial pain
and in orofacial motor control, there is a considerable evi-
dence that non-neuronal (glial) cells play an important
role both in peripheral and CNS neuronal mechanisms
underlying pathological pain. Although most of the recent
studies have mainly focused on the role of the hyperactive
microglial or astroglial cells in pain mechanisms, no data
have been reported whether hyperactive glial cells after
peripheral nerve injury have any role in modulation of oral
motor functions. In view of this and our findings of tri-
geminal motor neuronal changes and glial cell involve-
ment in IAN-X model of trigeminal neuropathic pain, the
present study focused on the possible sites of hyperactive
glial cells especially in prV and motV in the modulation of
masticatory jaw movements following IAN-X.
Various studies have reported that microglial cells dis-
play remarkable changes in their morphology and physi-
ology in response to various stimuli. The fact that
microglial cells are hyperactive in the Vc (medullary dorsal
horn) and the spinal dorsal horn (see review [14,16-18,53-
59] after spinal or trigeminal nerve injury. In addition,
some recent studies have shown that microglial cells are
activated in the areas surrounding the prV [19] and facial
motor nuclei [20] following trigeminal nerve injury. We
have also found that the microglial cells are activated both
in the prV and motV along with Vc after IAN-X.
Glial cells are known to be hyperactive at different
times courses after the nerve injury [14,18,57] such that
microglial cells in the Vc are activated around 3 days
after the injury and slightly reduced around 14 days [17-
19,59]. Consistent with the previous findings, we
observed that many Iba1-IR cells are expressed both in
the prV and motV and changed in their morphology
around 3 days after IAN-X, and the number of hyper-
active microglial cells was slightly reduced around 14 days
after IAN-X Figure 1A, C, D).
Regarding the role of these hyperactive microglial cells,
many researchers have reported that hyperactive micro-
glial cells have functional interactions with neurons in
many CNS regions [57,60,61]. Following nerve injury,
microglial cells produce various substances (such as
TNF-α, IL-1β, IL-6, IL-18, NO and BDNF) that affect the
neuronal excitability [58,59]. Although microglial glial
cells have been recognized for their role in initiating
neuropathic pain, but recent evidence suggests that
microglial cells may also play an important role incontrolling the activity of the neuronal networks under-
lying motor function. Regarding this, Mika et al. have
shown that blocking of the microglial cell activity signifi-
cantly improves the recovery of motor behavior (walking
patterns) after the chronic constriction injury of the sci-
atic nerve [28]. In consistent with the above observation,
we have found that the efficiency of the masticatory jaw
movements is decreased when the microglia cells were
hyperactive in the prV and motV. Thus, it is possible that
hyperactive microglial cells in the prV and motV release
proinlfamatory substances and change in the neuronal
excitability of trigeminal motor neurons, and thereby
modulates the masticatory jaw movement following IAN-
X. Furthermore, we cannot rule out the possibility that
microglial cells in the Vc may also participate in modula-
tion of masticatory jaw movements.
The effect of MC on the masticatory jaw movements
To confirm the possible contribution of the hyperactive
microglial cells in the modulation of masticatory jaw
movements after IAN-X, we studied the effect of MC on
neuropathic pain and motor behaviors recovery. MC, a
semisynthetic second generation tetracycline derivative
antibiotic with adequate penetration into the brain and
cerebrospinal fluid [62-64], has emerged as a potent in-
hibitor of microglial activation and proliferation. Recently,
it has been shown that MC attenuates the mechanical
allodynia and central sensitization in several animal mod-
els of tissue inflammation [16,17,65], traumatic nerve in-
jury and spinal cord injury [24-33] through the inhibition
of the microglial cell activation, and improve the motor
functions [28,66]. In consistent with the recent findings,
we have found that the injection of minocycline 16 h be-
fore the transection and then daily after the transection
for 14 days strongly attenuates the development of the
neuropathic pain in IAN-X rats. These findings is sup-
ported by our immunohistochemical data showing that
systemic administration of MC strongly attenuated the
microglial cell activation both in the prV and motV on day
14 after IAN-X as well as overcoming the impaired masti-
catory motor patterns that was typical in this model.
Conclusions
Our results suggest that the neuropathic pain associated
with the regeneration of IAN-X strongly affects mastica-
tion. The findings also indicate the possible contribution
of hyperactive microglia in the modulation of masticatory
motor function after regeneration of the transected IAN
and that activation of microglia in the prV and motV may
play an important role in modulation, since the microglial
inhibitor MC was effective to reduce the severity of neur-
algia and the associated nociceptive behaviors and
impaired masticatory behaviors. Our data also suggest that
MC may be a useful drug to treat the orofacial motor
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study will open new insights for clinicians to diagnose and
manage masticatory dysfunction after trigeminal nerve
injury.
Methods
The experiments were carried out in accordance with the
guidelines of National Institute of Health Guide for the
Care and Use of Laboratory (NIH Publication no. 80–23)
revised 1996 and the International Association for the
Study of Pain in conscious Animals [67], and were
approved by the intramural Animal Care and Veterinary
Science Committee of Niigata University. A total of 101
male Sprague–Dawley rats weighing 200–250 g were used
in this study. Rats were divided into four groups according
to their preparation (sham rats; n = 17, IAN-X rats; n = 42,
IAN-X+MC rats; n = 22, IAN-X+ saline rats; n = 20).
Inferior alveolar nerve transection (IAN-X)
Before IAN-X, the site of the transection was marked to
avoid the damage of the motor nerve. It has been
reported that the IAN entered the mandibular foramen as
a large single trunk and runs along the medial aspect of
the mandible through the mandibular canal (Additional
File 1: Figure S1Aa, Ab) [68]. Before enter to the man-
dibular foramen, the IAN gives off a motor nerve branch
namely the mylohyoid nerve which coursed anteriorly
along the lingual surface of the mandible in the mylo-
hyoid groove (Additional File 1: Figure S1Aa, Ab) [69].
Thus, it was decided to expose the IAN by making a
small hole on the external surface of the mandibular
canal since the IAN within the mandibular canal is almost
sensory in nature, and also the injury of this nerve does
not affect the peripheral representation of the auriculo-
temporal, mylohyoid, lingual and maxillary nerves [70].
The methods have been previously detailed [13,35]
and only a brief description follows. Rats were initially
anesthetized with sodium pentobarbital (initial dose,
50 mg/kg, i.p.). The adequacy of anesthesia was checked
repeatedly throughout the surgery by noxious pressing
the hind paw to determine if a withdrawal reflex was
evoked, and if so, a supplementary dose of sodium
pentobarbital was given.
For IAN-X, a small horizontal incision was made on
the surface of the facial skin over the masseter muscle
and the surface of the alveolar bone was exposed by dis-
secting the overlying tissues (Additional File 1: Figure
S1Ac). The alveolar bone over the IAN was removed
slowly with a small round bar (no: 6) and the IAN was
exposed (Additional File 1: Figure S1Ac). Then the
exposed IAN was lifted up from the mandibular canal
without any injury by the angulated thin glass rods and
transected just above the angle of the mandible (Add-
itional File 1: Figure S1Ad). The transected IAN wasplaced back in the mandibular canal without any discern-
able gap between its cut-ends (Additional File 1: Figure
S1Ae). It is notable that the mental and incisor branch of
the IAN was not discriminated in the present study.
In the case of sham rats, similar horizontal incision was
made on the facial skin, the exposed alveolar bone cover-
ing the IAN was removed, and the IAN was exposed and
left intact.
Drug administration
Minocycline (MC) was suspended in isotonic saline. The
MC solution (50 mg/kg body weight, Sigma, USA) or ve-
hicle (saline, 1 ml/day) was administrated intraperitone-
ally (i.p.) [28,34] 16 h before IAN-X, and the injection
was then given daily for next 14 days (Figure 6). The in-
fluence of MC on the head-withdrawal threshold to
mechanical stimulation of the mental skin was tested
once daily for 14 days after IAN-X.
In addition, MC or saline was given by microinjection
(m.i.) into the motV nucleus (Figure 6). A vertical incision
was made over the head skin to prepare a small hole in
the left side of over the occipital bone (9.5 mm posterior
and 2 mm lateral from the bregma point) for the MC ad-
ministration into the motV. The needle was inserted
(8.2 mm in depth) stereotaxically to the motV through the
hole, and the needle head was fixed with adhesive dental
acrylic. Then 0.1-0.05 μl of MC was administrated pre-
emptively into the motV 16 h before IAN-X and then daily
for the next 14 days (Figure 6).
Behavioral testing
Rats were trained daily to stay in a plastic cage without
any discomfort for 20 min, and protruded their perioral
region through a hole made in the wall of the plastic
cage as previously described [13,35]. The mechanical
head-withdrawal threshold was measured by using a
series of von-Frey filaments applied to the mental skin
(supplied by the IAN) and the whisker pad skin (sup-
plied by the infra-orbital nerve). One week after the
training, rats were capable of receiving mechanical
stimulation of the mental skin and whisker pad skin with
their perioral regions protruding the nose through the
hole for 20 min. Before the start of the training, water
was restricted to 50 ml/day for 2 days. In daily sessions,
water was used as a reward to train rats to stay in the
plastic cage and to drink water through the hole during
noxious stimulation of the mental skin and whisker pad
skin. The criterion performance was when the rats could
keep drinking water for 20 min without escape from
noxious stimulation applied by the von-Frey filaments to
the mental skin and whisker pad skin. The mechanical
head-withdrawal threshold was measured three times
both in ascending and descending orders, and the aver-
age value was used for analysis. The maximum stimulus
Figure 6 The time course of the present experiment. The rats were trained for behavioral testing at least 7 days before any surgical operation
and drug or chemical injection. After the training, the rats were prepared for the sham operation or IAN-X, and the behavioral test was
conducted for 14 days after the sham operation or IAN-X. In MC (both i.p. and m.i.) or saline (both i.p. and m.i.) injected rats, the drug was
injected 16 h before transection, and was administrated once in a daily for 14 days after IAN-X. After behavioral test, the rats were prepared either
for a second surgery prior to recording masticatory jaw movement or for perfusion prior to immunohistochemistry. In the case of IAN-X rats, the
perfusion was conducted at 3 and 14 day after IAN-X. Note that the masticatory jaw movement was recorded for at least 4 days.
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since each rat had a different head-withdrawal threshold
to mechanical stimulation. When a 70 g stimulus was
applied to the mental skin or whisker pad skin, all rats
showed escape behavior, and so 70 g was the strongest
stimulus intensity used for the nocifensive behavioral
testing. Such training sessions were continued until the
criterion performance was reached (Figure 6). After ces-
sion of the training, rats were prepared for sham oper-
ation or IAN-X, IAN-X+MC injection, or IAN-
X+ saline injection. After the surgery, the head-with-
drawal threshold to mechanical stimulation was mea-
sured once daily for 14 days (Figure 6). In the case of
IAN-X rats, when the head-withdrawal threshold was
between 2 to 8 g, these rats were prepared for recordings
of jaw movements and EMG activities from masseter
and digastric muscles (Figure 6).Jaw movements and EMG recordings
A total of 46 rats of the 101 rats were chosen at random
for the recordings of jaw movements and EMG activities
(sham rats; n = 7, 3 day IAN-X rats; n = 5, 7 day IAN-X
rats; n = 5, 14 day IAN-X rats; n = 7, 14 day IAN-X+MC
(i.p.) rats; n = 7, 14 day IAN-X+MC (m.i.) rats; n = 5,
14 day IAN-X+ saline (i.p.) rats; n = 5, 14 day IAN-X+
saline (m.i.) rats; n = 5) (Figure 6). Before surgery, the ani-
mals were anesthetized with sodium pentobarbital (initial
dose, 50 mg/kg, i.p.) and a small amount of lidocaine (2%)
was injected into the skin to abolish nociceptive signals by
the surgery.
A pair of bipolar multi-stranded, Teflon-coated stain-
less-steel wire electrodes was implanted bilaterally to rec-
ord EMG activities from the masseter and anterior
digastric muscles. A small cylindrical magnet
(4 × 4 mm) was fixed to the animal’s chin with adhesive
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dimensions (Vertical, horizontal and anterior/posterior
planes). A jaw-tracking system which consisted of four
magnetic sensors was attached to the head [71]. The
jaw-movement trajectories were traced as movements
of the magnet by four magnetic sensors during masti-
cation by the animals. Wires from the electrodes for
EMG recordings were led subcutaneously to a con-
nector fixed to the parietal bone.
After the animal had recovered from surgery, the
EMG activities of the jaw muscles and jaw movements
in three dimensions were recorded during mastication.
During the recording sessions, animals ate the test food
(pellets) in the plastic cage. Recordings were made daily
for 4 days, and each session lasted less than 1 h, and
were discontinued if the animals showed discomfort. At
the completion of the experiment, the animal was sacri-
ficed by an over-dose of sodium pentobarbital (80 mg/
kg, i.p.) administration, and the injection site and EMG
electrode locations were confirmed by post-mortem
dissection.
EMG activities were amplified using a custom-built
AC amplifier (band pass: 0.1–3 kHz), and EMG signals
and the jaw movement trajectories were digitized (sam-
pling rate: 2,000/s for EMGs, 300/s for jaw movement)
with the Spike2 analysis package (Cambridge Electronic
Design Ltd., Cambridge, UK). EMG activities and the
jaw-movement trajectories were stored in a hard disc
and analyzed offline.
Data analyses of jaw movements and EMG activities
For the analysis, the following off-line determinations
were made. First, the masticatory sequence was defined
as the period from the onset of the digastric burst asso-
ciated with mouth opening to obtain the food (initial jaw
opening) to the end of the cyclic jaw movements related
to mastication; the duration of this sequence was defined
as the masticatory sequence time (Figure 3A). The total
number of the masticatory sequences within 5 min of
the continuous recording was calculated. Next, each
masticatory sequence was divided into two masticatory
periods: the preparatory (PP) period (food intake and
transportation of food to the occlusal surface) and rhyth-
mic-chewing (RC) period (food is “chewed” by the op-
posing molars) (Figure 3). The masticatory sequence
always started with the food preparation and incision
(PP) followed by chewing (RC). The masticatory period
was determined on the basis of the jaw-movement pat-
terns (vertical, horizontal and anterior/posterior move-
ments) and the related jaw muscles EMG activity
patterns (Figure 3). At the early stage of mastication, ir-
regular cyclic open-close movements with small jaw-
closing muscle activities were observed. Since small jaw-
closing muscle indicates that strong bit force did notoccur, this period is considered as the period of food in-
take and transportation. The PP period was defined as
the period from the onset of the digastric burst related
to the initial jaw opening to the start of RC period
(Figure 3). Following the PP period, the jaw-movement
pattern changed abruptly to that with clear lateral shift
of the jaw in the jaw-closing phase (Figure 3). Such jaw
movements were characterized by large rhythmic jaw-
closing muscle bursts, indicating that the food is
“chewed” by the opposing molars, was termed as RC.
Thus, this period was defined as the period from the
onset of the marked masseter burst along with a prom-
inent lateral shift of the jaw to the end of the cyclic jaw
movements related to mastication (Figure 3). The dur-
ation of each masticatory period was calculated, and the
jaw-movement trajectories in the lateral plane (combin-
ation of vertical and horizontal jaw movements) were
analyzed during the RC period (Figure 4A). The jaw
movement patterns was divided into five types (i.e.,
Type-I, Type-II, Type-III, Type-IV and Type-V) on the
basis of the horizontal excursion of the lower jaw
(Figure 4B). For the chewing cycle, the duration from
the point of maximum jaw opening to the point of next
maximum opening in the vertical component of the jaw-
movement trajectories was calculated, and termed chew-
ing cycle duration. Furthermore, the following variables
were analyzed for each chewing cycle in each mastica-
tory period: 1) the number of chewing cycles within the
RC period, 2) the duration of chewing cycles and the
duration of jaw-closing and jaw-opening phases. The
jaw-closing phase was defined as that from maximum
jaw opening to minimum jaw opening, and the jaw-
opening phase as that from the end of the jaw-closing
phase to the following maximum jaw opening.
The duration of the masticatory sequence, each mastica-
tory period and chewing cycles were compared among
animal groups. In addition, more detailed analysis was per-
formed on EMG activities to evaluate if any changes oc-
curred. Analysis of EMG activities involved assessment of
the mean duration and area of the jaw-muscles activity.
For this, 10 complete masticatory sequences were ran-
domly selected for the analysis of the EMG for each of the
day. First, the averaged EMG value for each parameter
was calculated for each of the day. Then, the mean value
for 4 days was averaged together, and the mean of the
mean value of the EMG was obtained.Histology
In the case of the IAN-X+MC (m.i.) and IAN-X+ saline
(m.i.) rats, 4 M direct blue or pontamine blue was micro-
injected into the motV after completion of the recordings,
to locate the area of the microinjection. Then animals
were deeply anesthetized with sodium pentobarbital
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0.9% saline (500 ml) and 4% paraformaldehyde (500 ml).
The block of the brain was preserved in 4% paraformalde-
hyde for 3–4 days and then 20% sucrose in 0.01 M phos-
phate buffered saline (PBS, pH 7.4) for another 3–4 days
in 4 C temperature. Then 30 μm frozen sections were cut
and stained with cresyl violet to confirm the injection site
(Figure 1B).
Immunohistochemistry
On day 3 or 14 after IAN-X or on day 14 after IAN-
X+MC (both i.p. and m.i.) or IAN-X+saline (both i.p. and
m.i.), or on day 14 after sham operation, 5 rats were chosen
from each group at random for the immunohistochemical
study. Rats were anesthetized with sodium pentobarbital
(80 mg/kg body weight, i.p.) and transcardially perfused
with the 0.9% isotonic saline (500 ml) and sequentially with
fresh 4% paraformaldehyde in 0.1 M phosphate buffer (PB,
pH 7.4, 500 ml). The medulla and the pons were removed
and postfixed in 4% paraformaldehyde for 3 days at 4 °C
and then the tissues were transferred to 20% sucrose (w/v)
in 0.1 M PBS for several days for cryoprotection. Serial fro-
zen sections (30 μm thickness) were made through the me-
dulla and pons, and collected in 0.01 M cold PBS. Single
immunohistochemical procedures were performed at room
temperature unless otherwise stated. Free-floating sections
were washed with 0.01 M PBS (pH 7.4) for 10 min, and
kept by the blocking solutions containing 5% normal goat
serum and 0.1% triton X for 2 h at room temperature with
agitation. After 2 h, the sections were incubated in rabbit
polyclonal anti-Iba1 antibody (for labeling microglia,
1:1000; Wako, Japan) for 2 days at 4 °C with agitation. Two
days after that, sections were washed with PBS and incu-
bated in ant-rabbit Alexa Fluor 568 IgG (1:1000; Invitrogen)
for 3 h at room temperature with agitation. Then sections
were washed in PBS and were mounted and cover-slipped.
Images were captured by using the Keyence BZ-8000 fluor-
escence Microscope (Keyence, Japan). The present study
was mainly focused in prV and motV, since previous studies
have confirmed the activation of Iba1/microglia in the Vc
[17-19]. Thus, the total number of microglia in the prV and
motV were counted by using a computer-assisted imaging
analysis system (NIH Image, version 1.61).
Fluorogold (FG) tracing
FG tracing study was conducted on the trigeminal ganglion
(TG) in 20 rats (sham: n=5, 3 day IAN-X: n=5, 7 day
IAN-X: n=5, 14 day IAN-X: n=5). Rats were initially
anesthetized with the sodium pentobarbital (50 mg/kg, i.p.),
and 10 μl of 4% FG was injected subcutaneously in the
mental skin 1.5-2.0 mm lateral and 1.0-1.5 mm below the
edge of the lower lip and at a depth of 5 mm from the sur-
face. Two days after the FG injection, rats were
deeply anesthetized with the same anesthetics andtranscardially perfused with the 0.9% isotonic saline
(500 ml) and sequentially with fresh 4% paraformal-
dehyde in 0.1 M PB (500 ml). The TG was removed
and postfixed with the 4% paraformaldehyde for
2 days and the tissue was then transferred to 20%
sucrose (wt/vol) in 0.01 M PBS for several days for
cryoprotection. Serial frozen sections (16 μm thick-
ness) were made with a freezing microtome. The
sections were washed in PBS, serially mounted on
gelatin-coated slides and cover-slipped. Images were
captured by using the Keyence BZ-8000 fluorescence
Microscope (Keyence, Japan). The FG-labeled neu-
rons with clear nuclei were counted and their areas
were measured in the root of the third branch of the
trigeminal nerve by using computer-assisted imaging
analysis system (NIH Image, version 1.61).Statistical analysis
One way ANOVA with Dunnett’s test was conducted dur-
ing comparing the mechanical escape threshold between
pre and post IAN-X, pre and post IAN-X+MC, or pre and
post IAN-X+saline. Other statistical analysis was con-
ducted by using one way ANOVA with Tukey Test.
p< 0.05 was considered significant.Additional files
Additional file 1: Figure S1.
Additional file 2: Figure S2.Abbreviations
IAN: inferior alveolar nerve; IAN-X: inferior alveolar nerve transection;
prV: trigeminal principal sensory nucleus; motV: trigeminal motor nucleus;
Vc: trigeminal subnucleus caudalis; Iba1-IR: Iba1-immunoreactive;
MC: minocycline; i.p.: intraperitoneal injection; m.i.: microinjection;
PB: phosphate buffer; PBS: phosphate-buffered saline; FG: fluorogold;
TG: trigeminal ganglion; PP: preparatory period; RC: rhythmic-chewing
period; EMG: electromyography; CNS: central nervous system; CPG: central
pattern generator; Ver: vertical component of the jaw; Hor: horizontal
component of the jaw; Ant/post: anterior/posterior component of the jaw; R-
dig and L-dig: right and left digastric muscles; R-mass and L-mass: right and
left masseter muscles; ANOVA: analysis of variance.
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